Cargando…

Uptake of new antidiabetic medications in three emerging markets: a comparison between Brazil, China and Thailand

OBJECTIVES: New antidiabetic medications such as insulin analogues and thiazolidinediones have been introduced over the last decade. This study compares the uptake of new agents in three emerging pharmaceutical markets: Brazil, China, and Thailand. METHODS: Using longitudinal IMS Health sales data,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Christine Y, Emmerick, Isabel Cristina M, Stephens, Peter, Ross-Degnan, Dennis, Wagner, Anita K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4343056/ https://www.ncbi.nlm.nih.gov/pubmed/25815201 http://dx.doi.org/10.1186/s40545-014-0020-4

Ejemplares similares

The Brazilian private pharmaceutical market after the first ten years of the generics law
por: Bertoldi, Andréa Dâmaso, et al.
Publicado: (2019)

Impact of universal health insurance coverage in Thailand on sales and market share of medicines for non-communicable diseases: an interrupted time series study
por: Garabedian, Laura Faden, et al.
Publicado: (2012)

Sales of anti-cancer medicines; China, Indonesia, Kazakhstan, Malaysia, Philippines and Thailand
por: Ferrario, Alessandra, et al.
Publicado: (2020)

Farmácia Popular Program: changes in geographic accessibility of medicines during ten years of a medicine subsidy policy in Brazil
por: Emmerick, Isabel Cristina Martins, et al.
Publicado: (2015)

Brazilian generics market change after Farmácia Popular program
por: Bertoldi, Andréa Dâmaso, et al.
Publicado: (2019)

Barriers in household access to medicines for chronic conditions in three Latin American countries
por: Emmerick, Isabel Cristina Martins, et al.
Publicado: (2015)

Policies and Programs to Facilitate Access to Targeted Cancer Therapies in Thailand
por: Sruamsiri, Rosarin, et al.
Publicado: (2015)

Retrospective interrupted time series examining hypertension and diabetes medicines usage following changes in patient cost sharing in the ‘Farmácia Popular’ programme in Brazil
por: Emmerick, Isabel Cristina Martins, et al.
Publicado: (2017)

Access to medicines for acute illness in middle income countries in Central America
por: Emmerick, Isabel Cristina Martins, et al.
Publicado: (2013)

Hypertension and diabetes treatment affordability and government expenditures following changes in patient cost sharing in the “Farmácia popular” program in Brazil: an interrupted time series study
por: Emmerick, Isabel Cristina Martins, et al.
Publicado: (2020)

Applying a health system perspective to the evolving Farmácia Popular medicines access programme in Brazil
por: Luiza, Vera L, et al.
Publicado: (2018)

Utilization of oral antidiabetic medications in Taiwan following strategies to promote access to medicines for chronic diseases in community pharmacies
por: Hsu, Jason C, et al.
Publicado: (2015)

Patient access schemes in Asia-pacific markets: current experience and future potential
por: Lu, Christine Y, et al.
Publicado: (2015)

Expanding access to high-cost medicines through the E2 access program in Thailand: effects on utilisation, health outcomes and cost using an interrupted time-series analysis
por: Sruamsiri, Rosarin, et al.
Publicado: (2016)

Interrupted time-series analysis of the impact of generic market entry of antineoplastic products in China
por: Guan, Xiaodong, et al.
Publicado: (2018)

Uncertainty in an emerging market economy: evidence from Thailand
por: Apaitan, Tosapol, et al.
Publicado: (2021)

What are the volume and budget needs to provide chemotherapy to all children with acute lymphoblastic leukaemia in Thailand? Development and application of an estimation tool
por: Sruamsiri, Rosarin, et al.
Publicado: (2020)

Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces
por: Chen, Wen, et al.
Publicado: (2010)

Racial differences in long-term adherence to oral antidiabetic drug therapy: a longitudinal cohort study
por: Trinacty, Connie M, et al.
Publicado: (2009)

Quality use of medicines within universal health coverage: challenges and opportunities
por: Wagner, Anita K, et al.
Publicado: (2014)

Differences in reimbursement listing of anticancer therapies in China: an observational study
por: Guan, Xiaodong, et al.
Publicado: (2020)

Oral cancer patient’s profile and time to treatment initiation in the public health system in Rio de Janeiro, Brazil
por: da Conceição, Manoela Garcia Dias, et al.
Publicado: (2021)

Uptake of new antidiabetic medicines in 11 European countries
por: Mardetko, Nika, et al.
Publicado: (2021)

Influence of government price regulation and deregulation on the price of antineoplastic medications in China: a controlled interrupted time series study
por: Guan, Xiaodong, et al.
Publicado: (2019)

Medicines coverage and community-based health insurance in low-income countries
por: Vialle-Valentin, Catherine E, et al.
Publicado: (2008)

Costs and effectiveness of the supervision, performance assessment and recognition (SPARS) strategy for medicines management in Uganda
por: Kwesiga, Brendan, et al.
Publicado: (2019)

The impact of COVID‐19 on franchising in emerging markets: An example from Brazil
por: Bretas, Vanessa Pilla Galetti, et al.
Publicado: (2020)

Food safety in Thailand 4: comparison of pesticide residues found in three commonly consumed vegetables purchased from local markets and supermarkets in Thailand
por: Wanwimolruk, Sompon, et al.
Publicado: (2016)

Costs of hospital care for hypertension in an insured population without an outpatient medicines benefit: an observational study in the Philippines
por: Wagner, Anita K, et al.
Publicado: (2008)

Impact of pharmaceutical policy interventions on utilization of antipsychotic medicines in Finland and Portugal in times of economic recession: interrupted time series analyses
por: Leopold, Christine, et al.
Publicado: (2014)

A descriptive review of the methodologies used in household surveys on medicine utilization
por: Bertoldi, Andréa D, et al.
Publicado: (2008)

Marketing authorisation and pricing of FDA-approved cancer drugs in Brazil: a retrospective analysis
por: Ivama-Brummell, Adriana M., et al.
Publicado: (2023)

Using health markets to improve access to medicines: three case studies
por: Shroff, Zubin, et al.
Publicado: (2016)

Need for and Access to Health Care and Medicines: Are There Gender Inequities?
por: Wagner, Anita K., et al.
Publicado: (2013)

Health care payments in the asia pacific: validation of five survey measures of economic burden
por: Reddy, Sheila R, et al.
Publicado: (2013)

Article 3: 1-year impact of supervision, performance assessment, and recognition strategy (SPARS) on prescribing and dispensing quality in Ugandan health facilities
por: Trap, Birna, et al.
Publicado: (2020)

Access to and price trends of antidiabetic, antihypertensive, and antilipidemic drugs in outpatient settings of the Universal Coverage Scheme in Thailand
por: Limwattananon, Chulaporn, et al.
Publicado: (2019)

Pet snakes illegally marketed in Brazil: Climatic viability and establishment risk
por: Fonseca, Érica, et al.
Publicado: (2017)

Influenza Virus (H5N1) in Live Bird Markets and Food Markets, Thailand
por: Amonsin, Alongkorn, et al.
Publicado: (2008)

Three Novel Entomopathogenic Fungi From China and Thailand
por: Wei, De-Ping, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_od0bgujmg635pjcs215u5lhpbg